Article citationsMore>>

R. S. Herbst, S. G. Eckhardt, R. Kurzrock, S. Ebbinghaus, P. J. O’Dwyer, M. S. Gordon, W. Novotny, M. A. Goldwasser, T. M. Tohnya, B. L. Lum, et al., “Phase I Dose-Escalation Study of Recombinant Human Apo2L/ TRAIL, a Dual Proapoptotic Receptor Agonist, in Patients with Advanced Cancer,” Journal of Clinical Oncology, Vol. 28, No. 17, 2010, pp. 2839-2846. http://dx.doi.org/10.1200/JCO.2009.25.1991

has been cited by the following article:

• TITLE: Development of Small Molecules Activating TRAIL Apoptosis Pathway for Cancer Therapies

  AUTHORS: Anita C. Bellail, Chunhai Hao

  KEYWORDS: Apoptosis Pathway; Apoptosis Pathway

  JOURNAL NAME: Open Journal of Apoptosis, Vol.2 No.4, October 31, 2013

  ABSTRACT: Development of Small Molecules Activating TRAIL Apoptosis Pathway for Cancer Therapies